Abstract
Epigenetic modifications regulate chromatin folding and function. Epigenetic mechanisms regulate transcription mediating effects of various stimuli on gene expression. These mechanisms are involved in transcriptional control in various physiological and pathological conditions including neuropsychiatric disorders and behavioral abnormalities such as depression. In rodents, exposure to chronic social stress was shown to induce behavioral impairments and memory/learning deficits that resemble depressive-like phenotype in humans. The rodent models of chronic stress were widely used to study molecular mechanisms of depression. In these models, early exposure to chronic stress such as prenatal or postnatal stress induces long-term hyperactive stress responses, behavioral abnormalities, and functional impairments in brain function that persist in adulthood. Furthermore, these alterations can be transmitted to offspring of chronically stressed animals across several generations. Molecular studies in animal models showed that chronic stress induces stable epigenetic changes in specific brain regions, primarily in the limbic system. These changes lead to long-lasting abnormalities in behavior that persist in adulthood and can be transmitted to offspring. Treatment with epigenetically active antidepressants disrupts the abnormal stress-induced epigenetic programming and provides epigenetic patterns that resemble epigenetic background of stress resilient individuals.
Keywords: Animal model, depression, early life adversity, epigenetics, histone, methylation, chronic social stress.
Current Pharmaceutical Design
Title:Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models
Volume: 23 Issue: 44
Author(s): Dimitry A. Chistiakov , Yuri V. Bobryshev*Vladimir P. Chekhonin
Affiliation:
- School of Medicine, University of Western Sydney, Campbelltown, NSW,Australia
Keywords: Animal model, depression, early life adversity, epigenetics, histone, methylation, chronic social stress.
Abstract: Epigenetic modifications regulate chromatin folding and function. Epigenetic mechanisms regulate transcription mediating effects of various stimuli on gene expression. These mechanisms are involved in transcriptional control in various physiological and pathological conditions including neuropsychiatric disorders and behavioral abnormalities such as depression. In rodents, exposure to chronic social stress was shown to induce behavioral impairments and memory/learning deficits that resemble depressive-like phenotype in humans. The rodent models of chronic stress were widely used to study molecular mechanisms of depression. In these models, early exposure to chronic stress such as prenatal or postnatal stress induces long-term hyperactive stress responses, behavioral abnormalities, and functional impairments in brain function that persist in adulthood. Furthermore, these alterations can be transmitted to offspring of chronically stressed animals across several generations. Molecular studies in animal models showed that chronic stress induces stable epigenetic changes in specific brain regions, primarily in the limbic system. These changes lead to long-lasting abnormalities in behavior that persist in adulthood and can be transmitted to offspring. Treatment with epigenetically active antidepressants disrupts the abnormal stress-induced epigenetic programming and provides epigenetic patterns that resemble epigenetic background of stress resilient individuals.
Export Options
About this article
Cite this article as:
Chistiakov A. Dimitry , Bobryshev V. Yuri*, Chekhonin P. Vladimir , Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models, Current Pharmaceutical Design 2017; 23 (44) . https://dx.doi.org/10.2174/1381612823666171031110734
DOI https://dx.doi.org/10.2174/1381612823666171031110734 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
?Revolutionizing Cancer Treatment: Nano-Therapeutics Targeting Tumor Microenvironment?
This thematic issue explores the forefront of cancer treatment, centering on the groundbreaking potential of nano-therapeutics meticulously designed to target the tumor microenvironment. At its core, the issue aims to unravel the latest advancements in nanotechnology, showcasing innovative materials, formulations, and delivery systems that hold promise for redefining cancer therapeutics. ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Pharmacological Treatment of Nonalcoholic Fatty Liver
Current Medicinal Chemistry A New Biomarker with High Outcome Prediction in IgA Nephropathy
Recent Patents on Biomarkers Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
Current Pharmaceutical Design Human Platelets Express Authentic CB1 and CB2 Receptors
Current Neurovascular Research Update on Parenteral Nutrition-Associated Liver Disease: Pathogenesis and Management
Current Nutrition & Food Science Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults
Current Hypertension Reviews Risk-Benefit Perspectives in COX-2 Blockade
Current Drug Safety An Overview of Emerging Immunotargets of Genitourinary Tumors
Current Drug Targets The Epidemiology of Adiposity and Dementia
Current Alzheimer Research Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry Meet Our Co-Editor
Current Vascular Pharmacology Systemic Hypertension in Patients with Aortic Stenosis: Clinical Implications and Principles of Pharmacological Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Patents in Diagnosis of Preeclampsia
Recent Patents on Biomarkers Refined Echocardiographic Assessment and Contemporary Medical Treatment of Obstructive Hypertrophic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Alterations of Sex Differentiation in Males: From Candidate Genes to Diagnosis and Treatments
Current Pharmaceutical Design Subfractions and Subpopulations of HDL: An Update
Current Medicinal Chemistry Anabolic Androgenic Steroid (AAS) Related Deaths: Autoptic, Histopathological and Toxicological Findings
Current Neuropharmacology A Systematic Review of First Trimester Biochemical and Molecular Predictive Tests for Preeclampsia
Current Hypertension Reviews Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia
Current Genomics Aqueous Extract of <i>Cola nitida</i> and <i>Garcinia kola</i> Synergistically Enhances Hippocampal-hypothalamic Glutamate and Na+ /K+ -ATPase Activity in Male Wistar Rats
Current Drug Discovery Technologies